Hepatic oxidative drug metabolism in rats with experimental renal failure. 1977

A P Van Peer, and F M Belpaire

The activity of the drug-oxidizing system was investigated in liver homogenates of control and uraemic rats. Acute renal failure was achieved by ligation of the ureters or by intravenous injection of uranyl nitrate. In the uraemic state the concentration of cytochrome P450 and the activity of aniline hydroxylase were not significantly changed, but the activity of aminopyrine N-demethylase was significantly decreased. In rats the hepatic oxidizing enzymes are not induced by the uraemic state, in contrast to what has been suggested in man.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A P Van Peer, and F M Belpaire
March 1984, Biochemical pharmacology,
A P Van Peer, and F M Belpaire
January 2004, Seminars in dialysis,
A P Van Peer, and F M Belpaire
May 1979, British journal of pharmacology,
A P Van Peer, and F M Belpaire
July 1990, The Journal of nutrition,
A P Van Peer, and F M Belpaire
October 1989, Gastroenterology,
A P Van Peer, and F M Belpaire
January 1982, Przeglad lekarski,
A P Van Peer, and F M Belpaire
January 2003, Seminars in dialysis,
A P Van Peer, and F M Belpaire
January 1996, Revista do Hospital das Clinicas,
Copied contents to your clipboard!